241 – 250 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
2007) In Neurobiology of Aging(
- Contribution to journal › Article
-
Mark
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article
-
Mark
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
(
- Contribution to journal › Article
- 2006
-
Mark
Om möss och människor. Inte givet att fynd hos alzheimermöss kan appliceras i klinisk verklighet
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers for Alzheimer's Disease: Levels of beta-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival.
(
- Contribution to journal › Article
-
Mark
New regression models for long-term cognitive change in Donepezil treated Alzheimer patients.
2006) 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy(
- Contribution to conference › Poster
-
Mark
2-års resultat av rivastigmin (Exelon®) behandling vid Alzheimers sjukdom i klinisk vardag.
2006) Läkarstämman 2006(
- Contribution to conference › Poster